One of the world’s most ambitious collaborations to tackle the rise of drug resistant infections has launched at Imperial College London today.
At the official launch of the Antimicrobial Resistance Collaborative (ARC), Imperial’s President, Professor Alice Gast, welcomed VIPs including the UK Government’s Chief Medical Officer, Professor Dame Sally Davies and Sir Richard Sykes, Chairman of the Imperial College Healthcare NHS Trust.
Professor Gast said: “At Imperial we are attacking antimicrobial resistance from all angles. By bringing together leaders in microbiology, engineering, chemistry, clinical research, epidemiology, health economics, and more, we take a holistic approach to tackling this great threat to humanity.”
Imperial’s interdisciplinary initiative is focused on tackling the growing challenge of infectious diseases particularly those caused by microbes that have become resistant to existing drugs. For example, in some parts of the world, doctors face strains of tuberculosis and gonorrhoea that are essentially untreatable. In the fight against malaria, experts report that there are now just one or two antimalarial drugs that remain effective. And in UK hospitals there have been isolated outbreaks of highly resistant bacteria, known as Carbapenem Resistant Enterobacteriaceae (CRE), which is a rapidly growing international threat.